Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-04
2011-01-04
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S300000, C514S233200, C546S121000, C546S334000, C544S127000, C544S105000, C568S074000
Reexamination Certificate
active
07863269
ABSTRACT:
The invention relates to compounds of the formula Ihaving antithrombotic activity, which in particular inhibit the protease-activated receptor 1 (PAR1), processes for their preparation and use thereof as medicaments.
REFERENCES:
patent: 3790586 (1974-02-01), Irikura et al.
patent: 6063847 (2000-05-01), Chackalamannil et al.
patent: 7317124 (2008-01-01), Kleemann et al.
patent: 2004/0152736 (2004-08-01), Chackalamannil et al.
patent: 2 221 796 (1972-11-01), None
patent: 1 391 456 (2004-02-01), None
patent: 1391451 (2004-02-01), None
patent: 1 602 646 (2005-12-01), None
patent: 8502843 (1985-07-01), None
patent: WO 03/089428 (2003-10-01), None
patent: WO 2004/078721 (2004-09-01), None
patent: WO 2005/047240 (2005-05-01), None
Ziessel, R., et. al., Convenient and Multistep Preparation of Oligopyridines Bearing Multiple Dansyl and Nitroxide Radicals, Synthesis, (2003), vol. 14, pp. 2145-2154.
Art-Mohand, S., New and Convenient Method for Incorporation of Pentafluorosulfanyl (SF5) Substituents Into Aliphatic Organic Compounds, Organic Letters, vol. 4. No. 17, pp. 3013-3015, (2002).
Bowden, R. et. al., A New Method for the Synthesis of Aromatic Sulfurpentafluorides and Studies of the Stability of the Sulfurpentafluoride Group in Common Synthetic Transformations, Tetrahedron 2000, vol. 56 pp. 3399-3408.
Brass, S., et. al, Platelets and Proteases, Nature, vol. 413, (2001), pp. 26-27.
Cappelli, A., et. al., A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity, J. Med. Chem., (2004), vol. 47, pp. 1315-1318.
Choong, I. C., et. al., Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 Through the Use of Extended Tethering and Structure-Based Drug Design, J. Med. Chem., (2002), vol. 45, pp. 5005-5022.
Cui, J. J., et. al., Non-Covalent Thrombin Inhibitors Featuring P3-Heterocycles With P1-Bicyclic Arginine Surrogates, Bioorganic & Medicinal Chemistry Letters, vol. 12, (2002), pp. 2925-2930.
Hollenberg, et. al., International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors, Pharmacological Reviews, vol. 54, No. 2, pp. 203-217, (2002).
Lebsack, A. D., et. al.,, Identification and Synthesis of [1,2,4]Triazolo[3,4-a]Phthalazine Derivatives as High-Affinity Ligands to the a28-1 Subunit of Voltage Gated Calcium Channel, Bioorganic & Medicinal Chemistry Letters, vol. 14, pp. 2463-2467, (2004).
Saito, et. al.,, Facile Synthesis of 1,2,3,4-Tetrahydroisoquinolines Through Cyclization of 0,N-Acetals. II. 1) Syn-Processes of Isoquinolinequinone Antibiotics, Chem. Pharm. Bull., vol. 37, no. 6, pp. 1493-1499, (1989).
Czech Joerg
Heinelt Uwe
Hofmeister Armin
Ort Ronald G.
Rahmani Niloofar
Sanofi-Aventis
Seaman D. Margaret
LandOfFree
Imino-imidazo-pyridine derivatives having antithrombotic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imino-imidazo-pyridine derivatives having antithrombotic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imino-imidazo-pyridine derivatives having antithrombotic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2709049